Priyadarshini Jaishankar from 5825 Central Ave, Newark, CA 94560, age 50

D2 Antagonists, Methods Of Synthesis And Methods Of Use
view source
US Patent:

20120010228, Jan 12, 2012
Filed:

Jun 17, 2011
Appl. No.:

13/163592
Inventors:

Gary W. Luehr - Hayward CA, US
Arathi Sundaram - Fremont CA, US
Priyadarshini Jaishankar - Newark CA, US
Philip W. Payne - Sunnyvale CA, US
Pascal Druzgala - Santa Rosa CA, US
International Classification:

A61K 31/438
A61P 25/04
A61P 25/00
C07D 487/10
US Classification:

514278, 546 16
Abstract:

Provided are Dor Dantagonist compounds and pharmaceutical compositions of formula Iand pharmaceutically acceptable salts thereof, or isomers thereof, wherein R, Rand Rare as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine Dor Dreceptor from the compounds of the invention.

Methods And Compositions For Treating Epilepsy
view source
US Patent:

20220226508, Jul 21, 2022
Filed:

May 28, 2020
Appl. No.:

17/595823
Inventors:

- Oakland CA, US
Aliesha L. GRIFFIN - San Francisco CA, US
Adam R. RENSLO - Oakland CA, US
Priyadarshini JAISHANKAR - San Francisco CA, US
International Classification:

A61K 49/00
Abstract:

Provided, inter alia, are methods and compositions for treating epilepsy. In one aspect, provided herein is a method of selecting a compound for treating epilepsy, said method includes, contacting a test compound with 5-hydroxytryptamine-2B receptor (5-HT2B), and measuring the 5-HT2B agonistic activity of the test compound. In another aspect, provided herein is a method of treating an epilepsy in a subject in need thereof. The method includes administering to said subject an effective amount of a 5-HT2B specific receptor agonist.

Beta-Lactamase Inhibitors, Formulations, And Uses Thereof
view source
US Patent:

20180360857, Dec 20, 2018
Filed:

Jul 31, 2018
Appl. No.:

16/050601
Inventors:

- Tampa FL, US
- Oakland CA, US
Adam Renslo - Oakland CA, US
Priyadarshini Jaishankar - Newark CA, US
International Classification:

A61K 31/675
A61K 31/665
A61P 31/04
Abstract:

Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat bacterial infections. Also provided herein are methods of making and using the heterocyclic compounds and pharmaceutical formulations.

Compositions, Methods Of Use, And Methods Of Treatment
view source
US Patent:

20180333390, Nov 22, 2018
Filed:

Jul 30, 2018
Appl. No.:

16/049164
Inventors:

- Tampa FL, US
- Oakland CA, US
Orville Antonio Pemberton - Tampa FL, US
Xiujun Zhang - Lutz FL, US
Adam Renslo - San Francisco CA, US
Kyle Defrees - San Francisco CA, US
Priyadarshini Jaishankar - Newark CA, US
International Classification:

A61K 31/41
A61P 31/04
Abstract:

The present disclosure provides compositions including a beta-lactamase inhibitor, pharmaceutical compositions including a beta-lactamase inhibitor, methods of treatment of a condition (e.g., infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.

Compositions, Methods Of Use, And Methods Of Treatment
view source
US Patent:

20170088524, Mar 30, 2017
Filed:

Nov 8, 2016
Appl. No.:

15/345619
Inventors:

- Tampa FL, US
- Oakland CA, US
Adam R. Renslo - Oakland CA, US
Priyadarshini Jaishankar - Newark CA, US
Erica M. W. Lauterwasser - Hessheim, DE
International Classification:

C07D 257/04
A61K 31/4184
A61K 31/41
A61K 31/416
A61K 45/06
C07D 403/12
Abstract:

Embodiments of the present disclosure, in one aspect, relate to a beta-lactamase inhibitor, pharmaceutical compositions including a beta-lactamase inhibitor, methods of treatment of a condition (e.g., infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.

Compositions, Methods Of Use, And Methods Of Treatment
view source
US Patent:

20140378516, Dec 25, 2014
Filed:

Jan 4, 2013
Appl. No.:

14/370715
Inventors:

- Tampa FL, US
- Oakland CA, US
Adam R. Renslo - Oakland CA, US
Priyadarshini Jaishankar - Newark CA, US
Erica M.W. Lauterwasser - Wachenheim, DE
International Classification:

C07D 257/04
A61K 31/416
C07D 403/12
A61K 31/4184
A61K 31/41
A61K 45/06
US Classification:

514381, 548253
Abstract:

Embodiments of the present disclosure, in one aspect, relate to a beta-lactamase inhibitor, pharmaceutical compositions including a beta-lactamase inhibitor, methods of treatment of a condition (e.g., infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.

D2 Antagonists, Methods Of Synthesis And Methods Of Use
view source
US Patent:

20140350005, Nov 27, 2014
Filed:

Feb 19, 2014
Appl. No.:

14/184615
Inventors:

GARY W. LUEHR - HAYWARD CA, US
ARATHI SUNDARAM - FREMONT CA, US
PRIYADARSHINI JAISHANKAR - NEWARK CA, US
PHILIP W. PAYNE - SUNNYVALE CA, US
PASCAL DRUZGALA - SANTA ROSA CA, US
International Classification:

C07D 471/10
A61K 31/5377
A61K 31/439
A61K 31/435
A61K 45/06
A61K 31/4545
A61K 31/538
A61K 31/496
US Classification:

5142305, 5142358, 51425309, 514278, 544 70, 544230, 546 16, 546 20
Abstract:

Provided are Dor Dantagonist compounds and pharmaceutical compositions of formula Iand pharmaceutically acceptable salts thereof, or isomers thereof, wherein R, Rand Rare as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine Dor Dreceptor from the compounds of the invention.

Priyadarshini Jaishankar